APPB (Applied Biosciences) EBIT per Share: $-0.21 (TTM As of Dec. 2019)


APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences EBIT per Share?

Applied Biosciences APPB 12 EBIT per Share is $-0.21 as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's EBIT per Share for the three months ended in Dec. 2019 was $-0.10. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2019 was $-0.21.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Applied Biosciences's EBIT per Share or its related term are showing as below:

APPB's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.65
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Applied Biosciences's EBIT for the three months ended in Dec. 2019 was $-1.34 Mil.

Applied Biosciences  (OTCPK:APPB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Applied Biosciences EBIT per Share Related Terms

Applied Biosciences EBIT per Share Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences EBIT per Share Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
EBIT per Share
0.00 0.00 -0.00 -0.01 -0.16

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.01 -0.04 -0.06 -0.10
APPB
12GF Score
Applied Biosciences Corp APPB
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Applied Biosciences's EBIT per Share for the fiscal year that ended in Mar. 2018 is calculated as

EBIT per Share(A: Mar. 2018 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.387/15.071
=-0.16

Applied Biosciences's EBIT per Share for the quarter that ended in Dec. 2019 is calculated as

EBIT per Share(Q: Dec. 2019 )
=EBIT/Shares Outstanding (Diluted Average)
=-1.337/13.649
=-0.10

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.21 mean?
Applied Biosciences (APPB) has a EBIT per Share of $-0.21 as of Dec. 2019. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Applied Biosciences and its competitors.
Is Applied Biosciences' EBIT per Share too high?
Applied Biosciences' current EBIT per Share is $-0.21. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' EBIT per Share compare to CNABQ and OWCP?
Applied Biosciences' EBIT per Share of $-0.21 can be compared against companies in the Drug Manufacturers industry. The industry median EBIT per Share is 7.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Applied Biosciences and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Applied Biosciences's current EBIT per Share is $-0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current EBIT per Share of $-0.21. The current EBIT per Share is $-0.21. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Applied Biosciences (APPB), the current EBIT per Share is $-0.21 as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price